I, A., A, K., E, S., & J, M. (2026). From clinic to home: At-home neuromodulation for depression and the clinical significance of recent FDA approvals. Journal of affective disorders, 406, 121716. https://doi.org/10.1016/j.jad.2026.121716
Chicago Style (17th ed.) CitationI, Altinisik, Karimi A, Sun E, and Molina J. "From Clinic to Home: At-home Neuromodulation for Depression and the Clinical Significance of Recent FDA Approvals." Journal of Affective Disorders 406 (2026): 121716. https://doi.org/10.1016/j.jad.2026.121716.
MLA (9th ed.) CitationI, Altinisik, et al. "From Clinic to Home: At-home Neuromodulation for Depression and the Clinical Significance of Recent FDA Approvals." Journal of Affective Disorders, vol. 406, 2026, p. 121716, https://doi.org/10.1016/j.jad.2026.121716.